87 results on '"Pedersen, Jakob Skou"'
Search Results
2. Author response: circHIPK3 nucleates IGF2BP2 and functions as a competing endogenous RNA
3. Error-Corrected Deep Targeted Sequencing of Circulating Cell-Free DNA from Colorectal Cancer Patients for Sensitive Detection of Circulating Tumor DNA
4. Exploring the tumor genomic landscape of aggressive prostate cancer by whole‐genome sequencing of tissue or liquid biopsies
5. Author Response: circHIPK3 nucleates IGF2BP2 and functions as a competing endogenous RNA
6. circHIPK3 nucleates IGF2BP2 and functions as a competing endogenous RNA
7. circHIPK3 nucleates IGF2BP2 and functions as a competing endogenous RNA
8. Error-corrected deep targeted sequencing of circulating cell-free DNA from colorectal cancer patients for sensitive detection of circulating tumor DNA
9. circHIPK3 nucleates IGF2BP2 and functions as a competing endogenous RNA
10. Sequence dependencies and mutation rates of localized mutational processes in cancer
11. DREAMS: deep read-level error model for sequencing data applied to low-frequency variant calling and circulating tumor DNA detection
12. Supplementary Table S4 from Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma
13. Supplementary Table S4 from Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma
14. Data from Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma
15. Supplementary Figures S1-S19 from Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma
16. Data from Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma
17. Supplementary Table S1 from Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma
18. Supplementary Table S5 from Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma
19. Supplementary Table S6 from Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma
20. Supplementary Methods and References from Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma
21. Supplementary Table S2 from Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma
22. Supplementary Table S5 from Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma
23. Supplementary Table S2 from Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma
24. Supplementary Table S1 from Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma
25. Supplementary Table S3 from Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma
26. Supplementary Table and Figure Legend from Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma
27. Supplementary Methods and References from Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma
28. Supplementary Figures S1-S19 from Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma
29. Supplementary Table S6 from Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma
30. Supplementary Table S3 from Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma
31. Supplementary Table and Figure Legend from Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma
32. Epigenetic Silencing of LRP2 Is Associated with Dedifferentiation and Poor Survival in Multiple Solid Tumor Types
33. Pan-cancer association of DNA repair deficiencies with whole-genome mutational patterns
34. Author response: Pan-cancer association of DNA repair deficiencies with whole-genome mutational patterns
35. DREAMS: Deep Read-level Error Model for Sequencing data applied to low-frequency variant calling and circulating tumor DNA detection
36. Author Correction: Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis
37. Pan-cancer association of DNA repair deficiencies with whole-genome mutational patterns
38. The transcriptional landscape and biomarker potential of circular RNAs in prostate cancer
39. Sequence dependencies and mutation rates of localized mutational processes in cancer
40. The landscape and driver potential of site-specific hotspots across cancer genomes
41. miRNA activity inferred from single cell mRNA expression
42. Transcriptome-wide profiles of circular RNA and RNA-binding protein interactions reveal effects on circular RNA biogenesis and cancer pathway expression
43. Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis
44. miRNA activity inferred from single cell mRNA expression
45. Epigenetic and transcriptomic consequences of excess X‐chromosome material in 47,XXX syndrome—A comparison with Turner syndrome and 46,XX females
46. Transcriptome-wide profiles of circular RNA and RNA binding protein interactions reveal effects on circular RNA biogenesis and cancer pathway expression
47. Passenger Mutations in More Than 2,500 Cancer Genomes: Overall Molecular Functional Impact and Consequences
48. EBADIMEX: an empirical Bayes approach to detect joint differential expression and methylation and to classify samples
49. Deficiency of nucleotide excision repair is associated with mutational signature observed in cancer
50. Regmex: a statistical tool for exploring motifs in ranked sequence lists from genomics experiments
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.